|
Volumn 118, Issue , 2013, Pages 311-315
|
Cyclophilin-D inhibition in neuroprotection: dawn of a new era of mitochondrial medicine.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARSENOSOBENZENE;
CALCIUM;
CYCLOPHILIN;
CYCLOPHILIN D;
CYCLOSPORIN;
ENZYME INHIBITOR;
NEUROPROTECTIVE AGENT;
ORGANOARSENIC DERIVATIVE;
ANIMAL;
BRAIN INJURY;
DRUG EFFECT;
HUMAN;
ISCHEMIA;
METABOLISM;
MITOCHONDRION;
REVIEW;
ANIMALS;
ARSENICALS;
BRAIN INJURIES;
CALCIUM;
CYCLOPHILINS;
CYCLOSPORINE;
ENZYME INHIBITORS;
HUMANS;
ISCHEMIA;
MITOCHONDRIA;
NEUROPROTECTIVE AGENTS;
|
EID: 84881341425
PISSN: 00651419
EISSN: None
Source Type: None
DOI: 10.1007/978-3-7091-1434-6_61 Document Type: Review |
Times cited : (12)
|
References (0)
|